Technology and innovation watch
ShareMUMBAI: Glenmark Pharmaceuticals has gained the upper hand in a legal battle against Merck over a cholesterol control pill after a US court rejected most of the American drug company’s patent claims.
A New Jersey District court rejected 10 of the 13 patent claims after Glenmark challenged Merck’s patent so that it can launch [...]
ShareA U.S. judge ruled that some patent claims covering Merck & Co.’s cholesterol drug Zetia were invalid, but that other claims were valid.
Merck spokesman Ron Rogers said the company was disappointed in the judge’s split ruling, “but we continue to believe that Merck’s patent for Zetia is valid, enforceable, and that the [...]
Share
Merck & Co. said Monday it is suing to stop Novartis AG’s Sandoz division from selling a generic version of its antifungal drug Cancidas.
Filing the patent infringement lawsuit will keep the Food and Drug Administration from approving Sandoz’s generic for 30 months, or until the litigation is resolved. Whitehouse Station, N.J.-based Merck said Sandoz is [...]
ShareMerck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted [...]
Share
Generic giant Teva (Israel) has announced that the U.S. District Court of Delaware has issued a verdict in its favour by finding U.S. Patent No 5,260,291 unenforceable due to “inequitable conduct”. The indicated patent belongs to Merck &Co (U.S.) and protects the intellectual property rights on brain tumor drug Temodar (temozolomide). Merck has revealed that [...]
ShareDrug major Merck & Co said Tuesday that the U.S. District Court for the District of Delaware ruled against the company in a patent infringement suit against Teva Pharmaceuticals USA Inc. The suit is related to Merck’s chemotherapeutic agent Temodar’s patent.
The company said that in the ruling, Judge Sue Robinson said that Merck’s patent on [...]